This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sml Biopharm Co, Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hyo Jung Park: Innovator in Pharmaceutical Composition
Introduction
Hyo Jung Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance therapeutic efficacy.
Latest Patents
Hyo Jung Park holds a patent for a "Pharmaceutical Composition Containing Stabilized Nucleic Acid Adjuvant." This invention represents a crucial advancement in the formulation of pharmaceutical products, potentially improving their stability and effectiveness.
Career Highlights
Hyo Jung Park is associated with SML Biopharm Co., Ltd., where he applies his expertise in biopharmaceuticals. His work focuses on developing cutting-edge solutions that address various health challenges.
Collaborations
Hyo Jung Park collaborates with talented professionals in his field, including Eun Kyoung Bang and Hae Li Ko. These partnerships enhance the innovative capacity of their projects and contribute to the advancement of pharmaceutical research.
Conclusion
Hyo Jung Park's contributions to pharmaceutical innovation underscore his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile